Literature DB >> 2595417

Abdominoperineal resection for rectal carcinoma: perioperative risk factors.

N B Halpern1, C B Cox, J S Aldrete.   

Abstract

This retrospective review of 37 cases of abdominoperineal resection for adenocarcinoma sought to correlate preoperative clinical characteristics and intraoperative events with the likelihood of subsequent development of specific complications in the postoperative period. Mortality was 3% (1/37), and the complication rate was 76% (28/37), with urologic (49% [18/37]) and pulmonary (30% [11/37]) complications being the most common. Significant perioperative risk factors included a history of cardiac disease, current cardiac medications, diabetes mellitus, an abnormal preoperative electrocardiogram, and extended operation. Factors not associated with an increased risk included age, sex, a history of pulmonary disorders, previous abdominal operations, operative time, and need for transfusions, management of the pelvic peritoneum, or perineal drainage. Such information should reliably identify high-risk patients and therefore should be useful for selecting such patients for palliative or other limited techniques of tumor control.

Entities:  

Mesh:

Year:  1989        PMID: 2595417     DOI: 10.1097/00007611-198912000-00009

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Laparoscopic-assisted abdominoperineal resection for low rectal adenocarcinoma.

Authors:  K L Leung; S P Kwok; W Y Lau; W C Meng; C C Chung; P B Lai; K H Kwong
Journal:  Surg Endosc       Date:  2000-01       Impact factor: 4.584

Review 2.  Abdominoperineal resection for adenocarcinoma of the low rectum.

Authors:  D A Rothenberger; W D Wong
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

3.  Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery.

Authors:  V A Lawrence; S G Hilsenbeck; C D Mulrow; R Dhanda; J Sapp; C P Page
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.